0001759655-22-000054.txt : 20220422 0001759655-22-000054.hdr.sgml : 20220422 20220422123145 ACCESSION NUMBER: 0001759655-22-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220420 FILED AS OF DATE: 20220422 DATE AS OF CHANGE: 20220422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mehrotra Parth CENTRAL INDEX KEY: 0001858398 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 22844589 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD. STREET 2: SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 4 1 wf-form4_165064509268045.xml FORM 4 X0306 4 2022-04-20 0 0001759655 Privia Health Group, Inc. PRVA 0001858398 Mehrotra Parth PRIVIA HEALTH GROUP, INC. 950 N. GLEBE RD., SUITE 700 ARLINGTON VA 22203 0 1 0 0 President and COO Common Stock, $0.01 par value per share 2022-04-20 4 M 0 20000 2 A 117391 D Common Stock, $0.01 par value per share 2022-04-20 4 S 0 20000 27.93 D 97391 D Stock Option (Right to Purchase) 2.0 2022-04-20 4 M 0 20000 0 D 2018-08-28 2033-08-27 Common Stock 20000.0 1685692 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.69 to $28.43 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. /s/ Thomas Bartrum, as attorney-in-fact 2022-04-22